Literature DB >> 7810696

Renal hypertrophy is associated with upregulation of TGF-beta 1 gene expression in diabetic BB rat and NOD mouse.

K Sharma1, F N Ziyadeh.   

Abstract

Renal hypertrophy is an early feature of diabetes, and it may predispose the kidney to the eventual development of parenchymal dysfunction. Since we have previously demonstrated that short-term culture in high glucose concentration stimulates production of transforming growth factor-beta 1 (TGF-beta 1) in proximal tubular and glomerular mesangial cells, we postulated that this cytokine, which has potent regulatory effects on cellular growth and extracellular matrix production, is important in mediating diabetic renal disease. In this study we evaluated the gene and protein expression of TGF-beta 1 in the kidney of two rodent models of spontaneous insulin-dependent diabetes mellitus [the biobreeding (BB) rat and the nonobese diabetic (NOD) mouse]. In association with the appearance in both models of significant renal hypertrophy, TGF-beta 1 mRNA levels were increased threefold in the kidney of the diabetic BB rat after 3 days of diabetes and also threefold after 7-9 days in the NOD mouse. There was no increase in TGF-beta 1 transcripts in the livers of the diabetic animals, suggesting that this response is tissue specific. Immunohistochemical studies revealed that TGF-beta 1 protein is concordantly elevated in the cortical tubular cells of the diabetic kidney in both models. These results suggest that the stimulated expression of renal TGF-beta is an early manifestation of the involvement of the kidney by diabetes. Whether increased TGF-beta production in the diabetic kidney is a key promoter of diabetic renal manifestations (e.g., hypertrophy) deserves additional studies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7810696     DOI: 10.1152/ajprenal.1994.267.6.F1094

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  47 in total

1.  Targeted overexpression of protein kinase C beta2 isoform in myocardium causes cardiomyopathy.

Authors:  H Wakasaki; D Koya; F J Schoen; M R Jirousek; D K Ways; B D Hoit; R A Walsh; G L King
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

Review 2.  Uric acid as a mediator of diabetic nephropathy.

Authors:  Diana I Jalal; David M Maahs; Peter Hovind; Takahiko Nakagawa
Journal:  Semin Nephrol       Date:  2011-09       Impact factor: 5.299

3.  Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats.

Authors:  D Koya; M R Jirousek; Y W Lin; H Ishii; K Kuboki; G L King
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

4.  Renoprotective effects of anti-TGF-β antibody and antihypertensive therapies in Dahl S rats.

Authors:  Sydney R Murphy; Annette J Dahly-Vernon; Kathryn M J Dunn; Chun Cheng Andy Chen; Steven R Ledbetter; Jan M Williams; Richard J Roman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-04-25       Impact factor: 3.619

5.  Temporal characterization of the development of renal injury in FHH rats and FHH.1BN congenic strains.

Authors:  Jan Michael Williams; Marilyn Burke; Jozef Lazar; Howard J Jacob; Richard J Roman
Journal:  Am J Physiol Renal Physiol       Date:  2010-11-03

Review 6.  Diabetes and Kidney Disease: Role of Oxidative Stress.

Authors:  Jay C Jha; Claudine Banal; Bryna S M Chow; Mark E Cooper; Karin Jandeleit-Dahm
Journal:  Antioxid Redox Signal       Date:  2016-04-01       Impact factor: 8.401

7.  Heterozygous knockout of transforming growth factor-β1 protects Dahl S rats against high salt-induced renal injury.

Authors:  Chun Cheng Andy Chen; Aron M Geurts; Howard J Jacob; Fan Fan; Richard J Roman
Journal:  Physiol Genomics       Date:  2012-12-18       Impact factor: 3.107

Review 8.  New insights into molecular mechanisms of diabetic kidney disease.

Authors:  Shawn S Badal; Farhad R Danesh
Journal:  Am J Kidney Dis       Date:  2014-02       Impact factor: 8.860

9.  Role of upstream stimulatory factor 2 in diabetic nephropathy.

Authors:  Shuxia Wang
Journal:  Front Biol (Beijing)       Date:  2015-05-13

10.  Associations between metabolic dysregulation and circulating biomarkers of fibrosis: the Cardiovascular Health Study.

Authors:  Isha Agarwal; Nicole L Glazer; Eddy Barasch; Luc Djousse; John S Gottdiener; Joachim H Ix; Jorge R Kizer; Eric B Rimm; David S Siscovick; George L King; Ken J Mukamal
Journal:  Metabolism       Date:  2015-07-21       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.